MEDICAL PROPERTIES TRUST INC (MPT) Fundamental Analysis & Valuation

NYSE:MPT • US58463J3041

Current stock price

4.63 USD
-0.01 (-0.22%)
At close:
4.64 USD
+0.01 (+0.22%)
After Hours:

This MPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MPT Profitability Analysis

1.1 Basic Checks

  • MPT had negative earnings in the past year.
  • In the past year MPT had a positive cash flow from operations.
  • In multiple years MPT reported negative net income over the last 5 years.
  • MPT had a positive operating cash flow in each of the past 5 years.
MPT Yearly Net Income VS EBIT VS OCF VS FCFMPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • With a Return On Assets value of -1.85%, MPT is not doing good in the industry: 69.67% of the companies in the same industry are doing better.
  • The Return On Equity of MPT (-6.03%) is worse than 68.85% of its industry peers.
  • With a Return On Invested Capital value of 2.98%, MPT perfoms like the industry average, outperforming 57.38% of the companies in the same industry.
  • MPT had an Average Return On Invested Capital over the past 3 years of 1.86%. This is in line with the industry average of 3.11%.
  • The last Return On Invested Capital (2.98%) for MPT is above the 3 year average (1.86%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.85%
ROE -6.03%
ROIC 2.98%
ROA(3y)-7.26%
ROA(5y)-2.8%
ROE(3y)-21.08%
ROE(5y)-9%
ROIC(3y)1.86%
ROIC(5y)2.78%
MPT Yearly ROA, ROE, ROICMPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • MPT's Operating Margin of 55.53% is amongst the best of the industry. MPT outperforms 96.72% of its industry peers.
  • MPT's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 96.25%, MPT belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MPT has remained more or less at the same level.
Industry RankSector Rank
OM 55.53%
PM (TTM) N/A
GM 96.25%
OM growth 3Y-5.14%
OM growth 5Y-3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5Y-0.37%
MPT Yearly Profit, Operating, Gross MarginsMPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MPT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPT is destroying value.
  • Compared to 1 year ago, MPT has less shares outstanding
  • Compared to 5 years ago, MPT has more shares outstanding
  • MPT has a worse debt/assets ratio than last year.
MPT Yearly Shares OutstandingMPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
MPT Yearly Total Debt VS Total AssetsMPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 0.02, we must say that MPT is in the distress zone and has some risk of bankruptcy.
  • MPT has a worse Altman-Z score (0.02) than 72.13% of its industry peers.
  • The Debt to FCF ratio of MPT is 1117.91, which is on the high side as it means it would take MPT, 1117.91 years of fcf income to pay off all of its debts.
  • MPT's Debt to FCF ratio of 1117.91 is in line compared to the rest of the industry. MPT outperforms 58.20% of its industry peers.
  • MPT has a Debt/Equity ratio of 2.11. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.11, MPT is not doing good in the industry: 68.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.11
Debt/FCF 1117.91
Altman-Z 0.02
ROIC/WACC0.47
WACC6.32%
MPT Yearly LT Debt VS Equity VS FCFMPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 2.10 indicates that MPT has no problem at all paying its short term obligations.
  • The Current ratio of MPT (2.10) is better than 88.52% of its industry peers.
  • MPT has a Quick Ratio of 2.10. This indicates that MPT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.10, MPT belongs to the best of the industry, outperforming 88.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
MPT Yearly Current Assets VS Current LiabilitesMPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MPT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 89.39% over the past year.
  • The Revenue has decreased by -2.36% in the past year.
  • The Revenue has been decreasing by -4.89% on average over the past years.
EPS 1Y (TTM)89.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.35%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-14.27%
Revenue growth 5Y-4.89%
Sales Q2Q%16.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 60.25% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.56% on average over the next years.
EPS Next Y133.19%
EPS Next 2Y60.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.32%
Revenue Next 2Y6.03%
Revenue Next 3Y3.88%
Revenue Next 5Y3.56%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MPT Yearly Revenue VS EstimatesMPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPT Yearly EPS VS EstimatesMPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

3

4. MPT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MPT. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 49.83 indicates a quite expensive valuation of MPT.
  • Based on the Price/Forward Earnings ratio, MPT is valued a bit cheaper than 62.30% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. MPT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 49.83
MPT Price Earnings VS Forward Price EarningsMPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • MPT's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as MPT.
Industry RankSector Rank
P/FCF 319
EV/EBITDA 14.67
MPT Per share dataMPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • MPT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MPT's earnings are expected to grow with 60.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.25%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. MPT Dividend Analysis

5.1 Amount

  • MPT has a Yearly Dividend Yield of 7.71%, which is a nice return.
  • Compared to an average industry Dividend Yield of 7.54, MPT pays a bit more dividend than its industry peers.
  • MPT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 7.71%

5.2 History

  • The dividend of MPT decreases each year by -21.35%.
  • MPT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-21.35%
Div Incr YearsN/A
Div Non Decr YearsN/A
MPT Yearly Dividends per shareMPT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • MPT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-69.53%
EPS Next 2Y60.25%
EPS Next 3YN/A
MPT Yearly Income VS Free CF VS DividendMPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

More info and screens

Find the best dividend stocksShow peers with best dividend

MPT Fundamentals: All Metrics, Ratios and Statistics

MEDICAL PROPERTIES TRUST INC

NYSE:MPT (4/2/2026, 8:04:00 PM)

After market: 4.64 +0.01 (+0.22%)

4.63

-0.01 (-0.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-19
Earnings (Next)04-23
Inst Owners59.68%
Inst Owner ChangeN/A
Ins Owners17.76%
Ins Owner Change18.42%
Market Cap2.77B
Revenue(TTM)972.02M
Net Income(TTM)-277.94M
Analysts53.75
Price Target5.97 (28.94%)
Short Float %28.96%
Short Ratio18.39
Dividend
Industry RankSector Rank
Dividend Yield 7.71%
Yearly Dividend0.32
Dividend Growth(5Y)-21.35%
DP-69.53%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-12
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-834.32%
Min EPS beat(2)-1816.17%
Max EPS beat(2)147.53%
EPS beat(4)2
Avg EPS beat(4)-3339.11%
Min EPS beat(4)-11757.5%
Max EPS beat(4)147.53%
EPS beat(8)2
Avg EPS beat(8)-2222.45%
EPS beat(12)3
Avg EPS beat(12)-1454.49%
EPS beat(16)6
Avg EPS beat(16)-1085.69%
Revenue beat(2)2
Avg Revenue beat(2)5.9%
Min Revenue beat(2)0.7%
Max Revenue beat(2)11.11%
Revenue beat(4)3
Avg Revenue beat(4)2.59%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)11.11%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)5
Avg Revenue beat(12)-12.03%
Revenue beat(16)6
Avg Revenue beat(16)-9.77%
PT rev (1m)2.5%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.38%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.67%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.83
P/S 2.85
P/FCF 319
P/OCF 11.99
P/B 0.6
P/tB 0.6
EV/EBITDA 14.67
EPS(TTM)-0.28
EYN/A
EPS(NY)0.09
Fwd EY2.01%
FCF(TTM)0.01
FCFY0.31%
OCF(TTM)0.39
OCFY8.34%
SpS1.63
BVpS7.71
TBVpS7.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -6.03%
ROCE 3.77%
ROIC 2.98%
ROICexc 3.09%
ROICexgc 3.22%
OM 55.53%
PM (TTM) N/A
GM 96.25%
FCFM 0.89%
ROA(3y)-7.26%
ROA(5y)-2.8%
ROE(3y)-21.08%
ROE(5y)-9%
ROIC(3y)1.86%
ROIC(5y)2.78%
ROICexc(3y)1.91%
ROICexc(5y)2.85%
ROICexgc(3y)1.98%
ROICexgc(5y)2.93%
ROCE(3y)2.35%
ROCE(5y)3.52%
ROICexgc growth 3Y-9.84%
ROICexgc growth 5Y-5.4%
ROICexc growth 3Y-10.05%
ROICexc growth 5Y-5.8%
OM growth 3Y-5.14%
OM growth 5Y-3.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5Y-0.37%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.11
Debt/FCF 1117.91
Debt/EBITDA 11.93
Cap/Depr 81.41%
Cap/Sales 22.85%
Interest Coverage 1.18
Cash Conversion 28.4%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 0.02
F-Score5
WACC6.32%
ROIC/WACC0.47
Cap/Depr(3y)59.67%
Cap/Depr(5y)443.89%
Cap/Sales(3y)27.19%
Cap/Sales(5y)105.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.35%
EPS Next Y133.19%
EPS Next 2Y60.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-14.27%
Revenue growth 5Y-4.89%
Sales Q2Q%16.61%
Revenue Next Year7.32%
Revenue Next 2Y6.03%
Revenue Next 3Y3.88%
Revenue Next 5Y3.56%
EBIT growth 1Y39.53%
EBIT growth 3Y-18.68%
EBIT growth 5Y-8.21%
EBIT Next Year71.19%
EBIT Next 3Y20.45%
EBIT Next 5Y13.18%
FCF growth 1Y-85.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.99%
OCF growth 3Y-32.16%
OCF growth 5Y-17.87%

MEDICAL PROPERTIES TRUST INC / MPT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MEDICAL PROPERTIES TRUST INC (MPT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to MPT.


What is the valuation status of MEDICAL PROPERTIES TRUST INC (MPT) stock?

ChartMill assigns a valuation rating of 3 / 10 to MEDICAL PROPERTIES TRUST INC (MPT). This can be considered as Overvalued.


What is the profitability of MPT stock?

MEDICAL PROPERTIES TRUST INC (MPT) has a profitability rating of 4 / 10.


What is the financial health of MEDICAL PROPERTIES TRUST INC (MPT) stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPT) is 4 / 10.


What is the earnings growth outlook for MEDICAL PROPERTIES TRUST INC?

The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPT) is expected to grow by 133.19% in the next year.